This certificate recognizes Laurent Désiré's completion of a six-hour Good Clinical Practices course through the NIDA Clinical Trials Network. The course covered topics such as institutional review boards, informed consent, participant safety, research protocols, and investigational new drugs. Laurent Désiré passed all modules of the course, which was held on January 3, 2017 and is valid through January 3, 2020.
The role of real world data and evidence in building a sustainable & efficien...Office of Health Economics
This presentation defines RWD and RWE in the context of digital health, and looks at potential uses for RWD and RWE. It briefly sets out the current landscape in Malaysia and looks at the challenges in using RWE. In particular, the issues of access, governance and ensuring good quality are considered.
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019Akash Agnihotri
The New Drugs and Clinical Trials Rules, 2019 (NDCT Rules, 2019) apply to all new drugs, investigational new drugs for human use, clinical trials, bioequivalence studies, bioavailability studies, and ethics committees. The rules also apply to orphan drugs, phytopharmaceutical drugs, and biomedical and health research.
The role of real world data and evidence in building a sustainable & efficien...Office of Health Economics
This presentation defines RWD and RWE in the context of digital health, and looks at potential uses for RWD and RWE. It briefly sets out the current landscape in Malaysia and looks at the challenges in using RWE. In particular, the issues of access, governance and ensuring good quality are considered.
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019Akash Agnihotri
The New Drugs and Clinical Trials Rules, 2019 (NDCT Rules, 2019) apply to all new drugs, investigational new drugs for human use, clinical trials, bioequivalence studies, bioavailability studies, and ethics committees. The rules also apply to orphan drugs, phytopharmaceutical drugs, and biomedical and health research.
SAE REPORTING TIMELINE AND COMPENSATION 2019Shweta Lal
This presentation is based on New Drug and Clinical Trial Rule 2019 which was published in 19 march 2019. I have described chapter VI ( compensation) and Seventh Schedule including SAE reporting timeline in India.
WHODrug Koda, developed by Uppsala Monitoring Centre (UMC), is an automated coding service, which uses artificial intelligence (AI) to automate the coding of drug names and ATC selections, improving consistency and operational efficiency. It can also be used to accelerate dictionary upgrades, including the transition from WHODrug B2 format to B3.
Through API (Application Programming Interface) web services, the coding engine can be integrated with custom or off-the-shelf drug safety, medical coding, or data management systems.
In this webinar, Perficient and UMC discussed WHODrug Koda and how you can integrate it into your medical coding activities.
SAE REPORTING TIMELINE AND COMPENSATION 2019Shweta Lal
This presentation is based on New Drug and Clinical Trial Rule 2019 which was published in 19 march 2019. I have described chapter VI ( compensation) and Seventh Schedule including SAE reporting timeline in India.
WHODrug Koda, developed by Uppsala Monitoring Centre (UMC), is an automated coding service, which uses artificial intelligence (AI) to automate the coding of drug names and ATC selections, improving consistency and operational efficiency. It can also be used to accelerate dictionary upgrades, including the transition from WHODrug B2 format to B3.
Through API (Application Programming Interface) web services, the coding engine can be integrated with custom or off-the-shelf drug safety, medical coding, or data management systems.
In this webinar, Perficient and UMC discussed WHODrug Koda and how you can integrate it into your medical coding activities.
Intro to Web Development Part 1: HTML + CSSBasel Issmail
Fourth from series of workshop presentations about HTML and CSS for Those who want to learn how to design and build websites from scratch. Given by Basel Issmail.
Responsive Design, intro to Bootstrap.
UX, ethnography and possibilities: for Libraries, Museums and ArchivesNed Potter
These slides are adapted from a talk I gave at the Welsh Government's Marketing Awards for the LAM sector, in 2017.
It offers a primer on UX - User Experience - and how ethnography and design might be used in the library, archive and museum worlds to better understand our users. All good marketing starts with audience insight.
The presentation covers the following:
1) An introduction to UX
2) Ethnography, with definitions and examples of 7 ethnographic techniques
3) User-centred design and Design Thinking
4) Examples of UX-led changes made at institutions in the UK and Scandinavia
5) Next Steps - if you'd like to try out UX at your own organisation
How to Become a Thought Leader in Your NicheLeslie Samuel
Are bloggers thought leaders? Here are some tips on how you can become one. Provide great value, put awesome content out there on a regular basis, and help others.
Remote Patient Monitoring (RPM) - Enabling New Models of Care
NIDA Clinical Trials Network GCP training certificate-2017
1. NIDA Clinical Trials Network
Certificate of Completion
is hereby granted to
Laurent Désiré
to certify your completion of the six-hour required course on:
GOOD CLINICAL PRACTICES
MODULE: STATUS:
Introduction N/A
Institutional Review Boards Passed
Informed Consent Passed
Confidentiality & Privacy Passed
Participant Safety & Adverse Events Passed
Quality Assurance Passed
The Research Protocol Passed
Documentation & Record-Keeping Passed
Research Misconduct Passed
Roles & Responsibilities Passed
Recruitment & Retention Passed
Investigational New Drugs Passed
Course Completion Date: 3 January 2017
CTN Expiration Date: 3 January 2020
Tracee Williams, Training Coordinator
NIDA Clinical Coordinating Center
This training has been funded in whole or in part with Federal funds from the National Institute on Drug Abuse, National
Institutes of Health, Department of Health and Human Services, under Contract No. HHSN27201201000024C.
